MSD Pharma, on its defence, has said that the company follows the highest standards of ethics, compliance and regulations, which take precedence over business without any compromise. “Our support to CCEBDM(Certificate Course in Evidence BasedDiabetes Management) is in line with our philosophy of putting patients above all else. This multi-stakeholder programme is being managed by Public Health Foundation of India (PHFI) in association with Mohan’sDiabetes Education Academy, and is successfully addressing the much required capacity development needs among general physicians in the country for a rapidly growing disease like type 2 diabetes.
MSD strongly denies any allegations regarding this programme which have recently appeared in some sections of the media,” said an MSD spokesperson to an email query to ET.
When asked if he should have disclosed his association with MSD while writing the letter, Mohan said that it was just his view and the letter was to alert the ministry about the side affects. But Amar Jessani, editor, Indian Journal of Medical Ethics, says that least doctors can do in such a situation is disclose their association with pharma companies